Actin carbonylation: From cell dysfunction to organism disorder

Journal of Proteomics

Volumn 92, Issue , 2013, Pages 171-180

  Castro, José Pedro ^a,b,c   Jung, Tobias ^c   Grune, Tilman ^c   Almeida, Henrique ^a,b  

^a University of Porto   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Actin; Cellular dysfunction; Cytoskeleton; Degenerative disorders; Proteasome; Protein carbonylation

Indexed keywords

ACROLEIN; ACTIN; ADVANCED GLYCATION END PRODUCT; MEVINOLIN; PROANTHOCYANIDIN; UBIQUITIN CONJUGATING ENZYME E2; UBIQUITIN PROTEIN LIGASE; UBIQUITIN PROTEIN LIGASE E3;

ADRENAL CORTEX CELL; ALZHEIMER DISEASE; AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; BLADDER CANCER; CANCER CELL CULTURE; CANCER THERAPY; CARCINOGENESIS; CELL DEATH; CELL FUNCTION; CELL METABOLISM; CELL MOTION; CELL STRAIN CACO 2; CROSS LINKING; CYTOSKELETON; ENDOCYTOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FENTON REACTION; FUNCTIONAL DISEASE; GENE EXPRESSION; HUMAN; HUMAN GENOME; IMMUNODETECTION; IMMUNOLOGICAL SYNAPSE; INFERIOR PARIETAL LOBULE; MASS SPECTROMETRY; MILD COGNITIVE IMPAIRMENT; MUSCLE CONTRACTION; MYELOID LEUKEMIA; NONHUMAN; OBSERVATIONAL STUDY; OXIDATIVE STRESS; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CARBONYLATION; PROTEIN CONTENT; PROTEIN DEGRADATION; REVIEW; RING OPENING; SERTOLI CELL; SUPERFICIAL CANCER; TURNOVER TIME; WESTERN BLOTTING; YEAST CELL;

ANIMALIA;

ACTIN; CELLULAR DYSFUNCTION; CYTOSKELETON; DEGENERATIVE DISORDERS; PROTEASOME; PROTEIN CARBONYLATION;

ACTINS; AGING; ANIMALS; CELL AGING; HUMANS; OXIDATIVE STRESS; PROTEIN CARBONYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 84886953660     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2013.05.006     Document Type: Review

References (120)

1. Turrens J.F. Mitochondrial formation of reactive oxygen species. J Physiol 2003, 552:335-344.
2. Barja G., Herrero A. Localization at complex I and mechanism of the higher free radical production of brain nonsynaptic mitochondria in the short-lived rat than in the longevous pigeon. J Bioenerg Biomembr 1998, 30:235-243.
3. Zangar R.C., Davydov D.R., Verma S. Mechanisms that regulate production of reactive oxygen species by cytochrome P450. Toxicol Appl Pharmacol 2004, 199:316-331.
4. Curtis J.M., Hahn W.S., Long E.K., Burrill J.S., Arriaga E.A., Bernlohr D.A. Protein carbonylation and metabolic control systems. Trends Endocrinol Metab 2012, 23:399-406.
5. Förstermann U., Sessa W.C. Nitric oxide synthases: regulation and function. Eur Heart J 2012, 33:829-837.
6. Stadtman E.R., Levine R.L. Protein oxidation. Ann N Y Acad Sci 2000, 899:191-208.
7. Duan J., Kasper D.L. Oxidative depolymerization of polysaccharides by reactive oxygen/nitrogen species. Glycobiology 2011, 21:401-409.
8. Halliwell B.G.J. Free radicals in biology and medicine 2007, Oxford University Press Inc., New York.
9. Naskalski J.W., Bartosz G. Oxidative modifications of protein structures. Adv Clin Chem 2000, 35:161-253.
10. Grune T., Reinheckel T., Davies K.J. Degradation of oxidized proteins in mammalian cells. FASEB J 1997, 11:526-534.
11. Jung T., Bader N., Grune T. Lipofuscin. Ann N Y Acad Sci 2007, 1119:97-111.
12. Kastle M., Grune T. Protein oxidative modification in the aging organism and the role of the ubiquitin proteasomal system. Curr Pharm Des 2011, 17:4007-4022.
13. Mary J., Vougier S., Picot C.R., Perichon M., Petropoulos I., Friguet B. Enzymatic reactions involved in the repair of oxidized proteins. Exp Gerontol 2004, 39:1117-1123.
14. Shringarpure R., Grune T., Davies K.J. Protein oxidation and 20S proteasome-dependent proteolysis in mammalian cells. Cell Mol Life Sci 2001, 58:1442-1450.
15. Voss P., Hajimiragha H., Engels M., Ruhwiedel C., Calles C., Schroeder P., et al. Irradiation of GAPDH: a model for environmentally induced protein damage. Biol Chem 2007, 388:583-592.
16. Shringarpure R., Davies K.J.A. Protein turnover by the proteasome in aging and disease. Free Radic Biol Med 2002, 32:1084-1089.
17. Dalle-Donne I., Giustarini D., Colombo R., Rossi R., Milzani A. Protein carbonylation in human diseases. Trends Mol Med 2003, 9:169-176.
18. Nystrom T. Role of oxidative carbonylation in protein quality control and senescence. EMBO J 2005, 24:1311-1317.
19. Møller I.M., Rogowska-Wrzesinska A., Rao R.S.P. Protein carbonylation and metal-catalyzed protein oxidation in a cellular perspective. J Proteomics 2011, 74:2228-2242.
20. Lasch P., Petras T., Ullrich O., Backmann J., Naumann D., Grune T. Hydrogen peroxide-induced structural alterations of RNAse A. J Biol Chem 2001, 276:9492-9502.
21. Grune T., Merker K., Sandig G., Davies K.J.A. Selective degradation of oxidatively modified protein substrates by the proteasome. Biochem Biophys Res Commun 2003, 305:709-718.
22. Grune T., Jung T., Merker K., Davies K.J.A. Decreased proteolysis caused by protein aggregates, inclusion bodies, plaques, lipofuscin, ceroid, and 'aggresomes' during oxidative stress, aging, and disease. Int J Biochem Cell Biol 2004, 36:2519-2530.
23. Petrov D., Zagrovic B. Microscopic analysis of protein oxidative damage: effect of carbonylation on structure, dynamics, and aggregability of villin headpiece. J Am Chem Soc 2011, 133:7016-7024.
24. Hohn A., Jung T., Grimm S., Catalgol B., Weber D., Grune T. Lipofuscin inhibits the proteasome by binding to surface motifs. Free Radic Biol Med 2011, 50:585-591.
25. Höhn A., Sittig A., Jung T., Grimm S., Grune T. Lipofuscin is formed independently of macroautophagy and lysosomal activity in stress-induced prematurely senescent human fibroblasts. Free Radic Biol Med 2012, 53:1760-1769.
26. Grune T., Reinheckel T., Ja North, Li R., Pb Bescos, Shringarpure R., et al. Ezrin turnover and cell shape changes catalyzed by proteasome in oxidatively stressed cells. FASEB J 2002, 16:1602-1610.
27. Kueper T., Grune T., Prahl S., Lenz H., Welge V., Biernoth T., et al. Vimentin is the specific target in skin glycation. Structural prerequisites, functional consequences, and role in skin aging. J Biol Chem 2007, 282:23427-23436.
28. Kueper T., Grune T., Muhr G.-M., Lenz H., Wittern K.-P., Wenck H., et al. Modification of Vimentin. Ann N Y Acad Sci 2008, 1126:328-332.
29. Sitte N., Merker K., von Zglinicki T., Grune T. Protein oxidation and degradation during proliferative senescence of human MRC-5 fibroblasts. Free Radic Biol Med 2000, 28:701-708.
30. Grune T. Oxidative stress, aging and the proteasomal system. Biogerontology 2000, 1:31-40.
31. Sitte N., Huber M., Grune T., Ladhoff A., Doecke W.D., Von Zglinicki T., et al. Proteasome inhibition by lipofuscin/ceroid during postmitotic aging of fibroblasts. FASEB J 2000, 14:1490-1498.
32. Shringarpure R., Grune T., Sitte N., Davies K.J. 4-Hydroxynonenal-modified amyloid-beta peptide inhibits the proteasome: possible importance in Alzheimer's disease. Cell Mol Life Sci 2000, 57:1802-1809.
33. Jolly R.D., Douglas B.V., Davey P.M., Roiri J.E. Lipofuscin in bovine muscle and brain: a model for studying age pigment. Gerontology 1995, 41(Suppl. 2):283-295.
34. Hohn A., Jung T., Grimm S., Grune T. Lipofuscin-bound iron is a major intracellular source of oxidants: role in senescent cells. Free Radic Biol Med 2010, 48:1100-1108.
35. Catalgol B., Ziaja I., Breusing N., Jung T., Hohn A., Alpertunga B., et al. The proteasome is an integral part of solar ultraviolet a radiation-induced gene expression. J Biol Chem 2009, 284:30076-30086.
36. Kästle M., Woschee E., Grune T. Histone deacetylase 6 (HDAC6) plays a crucial role in p38MAPK-dependent induction of heme oxygenase-1 (HO-1) in response to proteasome inhibition. Free Radic Biol Med 2012, 53:2092-2101.
37. Hild G., Bugyi B., Nyitrai M. Conformational dynamics of actin: effectors and implications for biological function. Cytoskeleton 2010, 67:609-629.
38. Jones L.J.F., Carballido-López R., Errington J. Control of cell shape in bacteria: helical, actin-like filaments in Bacillus subtilis. Cell 2001, 104:913-922.
39. Pollard T.D., Cooper J.A. Actin, a central player in cell shape and movement. Science 2009, 326:1208-1212.
40. Herman I.M. Actin isoforms. Curr Opin Cell Biol 1993, 5:48-55.
41. Orlova A., Chen X., Rubenstein P.A., Egelman E.H. Modulation of yeast F-actin structure by a mutation in the nucleotide-binding cleft. J Mol Biol 1997, 271:235-243.
42. Dalle-Donne I., Rossi R., Giustarini D., Gagliano N., Lusini L., Milzani A., et al. Actin carbonylation: from a simple marker of protein oxidation to relevant signs of severe functional impairment. Free Radic Biol Med 2001, 31:1075-1083.
43. Lassing I., Schmitzberger F., Björnstedt M., Holmgren A., Nordlund P., Schutt C.E., et al. Molecular and structural basis for redox regulation of β-Actin. J Mol Biol 2007, 370:331-348.
44. Farah M.E., Sirotkin V., Haarer B., Kakhniashvili D., Amberg D.C. Diverse protective roles of the actin cytoskeleton during oxidative stress. Cytoskeleton 2011, 68:340-354.
45. Dalle-Donne I., Rossi R., Giustarini D., Gagliano N., Di Simplicio P., Colombo R., et al. Methionine oxidation as a major cause of the functional impairment of oxidized actin. Free Radic Biol Med 2002, 32:927-937.
46. Liu F., Li X.L., Lin T., He D.W., Wei G.H., Liu J.H., et al. The cyclophosphamide metabolite, acrolein, induces cytoskeletal changes and oxidative stress in Sertoli cells. Mol Biol Rep 2012, 39:493-500.
47. Canton M., Neverova I., Menabò R., Van Eyk J., Di Lisa F. Evidence of myofibrillar protein oxidation induced by postischemic reperfusion in isolated rat hearts. Am J Physiol Heart Circ Physiol 2004, 286:H870-H877.
48. Castro J.P., Ott C., Jung T., Grune T., Almeida H. Carbonylation of the cytoskeletal protein actin leads to aggregate formation. Free Radic Biol Med 2012, 53:916-925.
49. Kim E., Bobkova E., Hegyi G., Muhlrad A., Reisler E. Actin cross-linking and inhibition of the actomyosin motor. Biochemistry 2001, 41:86-93.
50. Nagasawa T., Hatayama T., Watanabe Y., Tanaka M., Niisato Y., Kitts D.D. Free Radical-mediated effects on skeletal muscle protein in rats treated with Fe-nitrilotriacetate. Biochem Biophys Res Commun 1997, 231:37-41.
51. Drake S.K., Bourdon E., Wehr N.B., Levine R.L., Backlund P.S., Yergey A.L., et al. Numerous proteins in mammalian cells are prone to iron-dependent oxidation and proteasomal degradation. Dev Neurosci 2002, 24:114-124.
52. Fratelli M., Demol H., Puype M., Casagrande S., Eberini I., Salmona M., et al. Identification by redox proteomics of glutathionylated proteins in oxidatively stressed human T lymphocytes. Proc Natl Acad Sci 2002, 99:3505-3510.
53. Stagsted J., Bendixen E., Andersen H.J. Identification of specific oxidatively modified proteins in chicken muscles using a combined immunologic and proteomic approach. J Agric Food Chem 2004, 52:3967-3974.
54. Tang Y., Forsyth C.B., Banan A., Fields J.Z., Keshavarzian A. Oats supplementation prevents alcohol-induced gut leakiness in rats by preventing alcohol-induced oxidative tissue damage. J Pharmacol Exp Ther 2009, 329:952-958.
55. Chung W.-G., Miranda C.L., Stevens J.F., Maier C.S. Hop proanthocyanidins induce apoptosis, protein carbonylation, and cytoskeleton disorganization in human colorectal adenocarcinoma cells via reactive oxygen species. Food Chem Toxicol 2009, 47:827-836.
56. Banan A., Zhang Y., Losurdo J., Keshavarzian A. Carbonylation and disassembly of the F-actin cytoskeleton in oxidant induced barrier dysfunction and its prevention by epidermal growth factor and transforming growth factor α in a human colonic cell line. Gut 2000, 46:830-837.
57. Barth B.M., Stewart-Smeets S., Kuhn T.B. Proinflammatory cytokines provoke oxidative damage to actin in neuronal cells mediated by Rac1 and NADPH oxidase. Mol Cell Neurosci 2009, 41:274-285.
58. Pazos M., da Rocha A.P., Roepstorff P., Rogowska-Wrzesinska A. Fish proteins as targets of ferrous-catalyzed oxidation: identification of protein carbonyls by fluorescent labeling on two-dimensional gels and MALDI-TOF/TOF mass spectrometry. J Agric Food Chem 2011, 59:7962-7977.
59. McDonagh B., Tyther R., Sheehan D. Carbonylation and glutathionylation of proteins in the blue mussel Mytilus edulis detected by proteomic analysis and Western blotting: actin as a target for oxidative stress. Aquat Toxicol 2005, 73:315-326.
60. Marco-Ramell A., Pato R., Peña R., Saco Y., Manteca X., Ruiz de la Torre J.L., et al. Identification of serum stress biomarkers in pigs housed at different stocking densities. Vet J 2011, 190:e66-e71.
61. Stark R., Liebes L., Nevrla D., Conklyn M., Silber R. Decreased actin content of lymphocytes from patients with chronic lymphocytic leukemia. Blood 1982, 59:536-541.
62. Nagata K., Sagara J., Ichikawa Y. Changes in contractile proteins during differentiation of myeloid leukemia cells. I. Polymerization of actin. J Cell Biol 1980, 85:273-282.
63. Cheitlin R., Ramachandran J. Regulation of actin in rat adrenocortical cells by corticotropin. J Biol Chem 1981, 256:3156-3158.
64. Bray D., Thomas C. The actin content of fibroblasts. Biochem J 1975, 147:221-228.
65. Mirzaei H., Regnier F. Identification of yeast oxidized proteins: chromatographic top-down approach for identification of carbonylated, fragmented and cross-linked proteins in yeast. J Chromatogr A 2007, 1141:22-31.
66. Tamarit J., Cabiscol E., Ros J. Identification of the major oxidatively damaged proteins in Escherichia coli cells exposed to oxidative stress. J Biol Chem 1998, 273:3027-3032.
67. Luo S., Levine R.L. Methionine in proteins defends against oxidative stress. FASEB J 2009, 23:464-472.
68. Das N., Levine R.L., Orr W.C., Sohal R.S. Selectivity of protein oxidative damage during aging in Drosophila melanogaster. Biochem J 2001, 360:209-216.
69. Selden L.A., Kinosian H.J., Estes J.E., Gershman L.C. Cross-linked dimers with nucleating activity in actin prepared from muscle acetone powder. Biochemistry 1999, 39:64-74.
70. Nørrelykke M.R., Baron C.P., Jessen F. Identification of carbonylated protein in frozen rainbow trout (Oncorhynchus mykiss) fillets and development of protein oxidation during frozen storage. J Agric Food Chem 2006, 54:9437-9446.
71. Selden L.A., Kinosian H.J., Newman J., Lincoln B., Hurwitz C., Gershman L.C., et al. Severing of F-actin by the amino-terminal half of gelsolin suggests internal cooperativity in gelsolin. Biophys J 1998, 75:3092-3100.
72. Kong J.Y., Rabkin S.W. Cytoskeletal actin degradation induced by lovastatin in cardiomyocytes is mediated through caspase-2. Cell Biol Int 2004, 28:781-790.
73. Sharp W.W., Terracio L., Borg T.K., Samarel A.M. Contractile activity modulates actin synthesis and turnover in cultured neonatal rat heart cells. Circ Res 1993, 73:172-183.
74. Kudryashova E., Kudryashov D., Kramerova I., Spencer M.J. Trim32 is a ubiquitin ligase mutated in limb girdle muscular dystrophy type 2H that binds to skeletal muscle myosin and ubiquitinates actin. J Mol Biol 2005, 354:413-424.
75. Grune T., Reinheckel T., Joshi M., Davies K.J.A. Proteolysis in cultured liver epithelial cells during oxidative stress: role of the multicatalytic proteinase complex, proteasome. J Biol Chem 1995, 270:2344-2351.
76. Grune T., Reinheckel T., Davies K.J.A. Degradation of oxidized proteins in K562 human hematopoietic cells by proteasome. J Biol Chem 1996, 271:15504-15509.
77. Davies K.J., Shringarpure R. Preferential degradation of oxidized proteins by the 20S proteasome may be inhibited in aging and in inflammatory neuromuscular diseases. Neurology 2006, 66:S93-S96.
78. Höhn A., Jung T., Grimm S., Catalgol B., Weber D., Grune T. Lipofuscin inhibits the proteasome by binding to surface motifs. Free Radic Biol Med 2011, 50:585-591.
79. Jung T., Catalgol B., Grune T. The proteasomal system. Mol Aspects Med 2009, 30:191-296.
80. Ullrich O., Reinheckel T., Sitte N., Hass R., Grune T., Davies K.J.A. Poly-ADP ribose polymerase activates nuclear proteasome to degrade oxidatively damaged histones. Proc Natl Acad Sci 1999, 96:6223-6228.
81. Kästle M., Grune T. Proteins bearing oxidation-induced carbonyl groups are not preferentially ubiquitinated. Biochimie 2011, 93:1076-1079.
82. Kästle M., Reeg S., Rogowska-Wrzesinska A., Grune T. Chaperones, but not oxidized proteins, are ubiquitinated after oxidative stress. Free Radic Biol Med 2012, 53:1468-1477.
83. Reinheckel T., Sitte N., Ullrich O., Kuckelkorn U., Davies K.J., Grune T. Comparative resistance of the 20S and 26S proteasome to oxidative stress. Biochem J 1998, 335(Pt 3):637-642.
84. Shringarpure R., Grune T., Mehlhase J., Davies K.J.A. Ubiquitin conjugation is not required for the degradation of oxidized proteins by proteasome. J Biol Chem 2003, 278:311-318.
85. Grimm S., Hohn A., Grune T. Oxidative protein damage and the proteasome. Amino Acids 2012, 42:23-38.
86. Powell S.R., Gurzenda E.M., Wahezi S.E. Actin is oxidized during myocardial ischemia. Free Radic Biol Med 2001, 30:1171-1176.
87. Divald A., Powell S.R. Proteasome mediates removal of proteins oxidized during myocardial ischemia. Free Radic Biol Med 2006, 40:156-164.
88. Milzani A., Rossi R., Di Simplicio P., Giustarini D., Colombo R., DalleDonne I. The oxidation produced by hydrogen peroxide on Ca-ATP-G-actin. Protein Sci 2000, 9:1774-1782.
89. DalleDonne I., Milzani A., Colombo R. The tert-butyl hydroperoxide-induced oxidation of actin Cys-374 is coupled with structural changes in distant regions of the protein. Biochemistry 1999, 38:12471-12480.
90. Sitte N., Merker K., Von Zglinicki T., Grune T., Davies K.J. Protein oxidation and degradation during cellular senescence of human BJ fibroblasts: part I-effects of proliferative senescence. FASEB J 2000, 14:2495-2502.
91. Sitte N., Merker K., Von Zglinicki T., Davies K.J., Grune T. Protein oxidation and degradation during cellular senescence of human BJ fibroblasts: part II-aging of nondividing cells. FASEB J 2000, 14:2503-2510.
92. Jung T., Hohn A., Catalgol B., Grune T. Age-related differences in oxidative protein-damage in young and senescent fibroblasts. Arch Biochem Biophys 2009, 483:127-135.
93. Breusing N., Arndt J., Voss P., Bresgen N., Wiswedel I., Gardemann A., et al. Inverse correlation of protein oxidation and proteasome activity in liver and lung. Mech Ageing Dev 2009, 130:748-753.
94. Levine R.L., Stadtman E.R. Oxidative modification of proteins during aging. Exp Gerontol 2001, 36:1495-1502.
95. Harman D. About "origin and evolution of the free radical theory of aging: a brief personal history, 1954-2009". Biogerontology 2009, 10:783.
96. Poon H.F., Vaishnav R.A., Getchell T.V., Getchell M.L., Butterfield D.A. Quantitative proteomics analysis of differential protein expression and oxidative modification of specific proteins in the brains of old mice. Neurobiol Aging 2006, 27:1010-1019.
97. Bizzozero O., Reyes S., Ziegler J., Smerjac S. Lipid peroxidation scavengers prevent the carbonylation of cytoskeletal brain proteins induced by glutathione depletion. Neurochem Res 2007, 32:2114-2122.
98. Revett T.J., Baker G.B., Jhamandas J., Kar S. Glutamate system, amyloid ss peptides and tau protein: functional interrelationships and relevance to Alzheimer disease pathology. J Psychiatry Neurosci 2013, 38:6-23.
99. Keck S., Nitsch R., Grune T., Ullrich O. Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer's disease. J Neurochem 2003, 85:115-122.
100. Poppek D., Keck S., Ermak G., Jung T., Stolzing A., Ullrich O., et al. Phosphorylation inhibits turnover of the tau protein by the proteasome: influence of RCAN1 and oxidative stress. Biochem J 2006, 400:511-520.
101. Grune T., Botzen D., Engels M., Voss P., Kaiser B., Jung T., et al. Tau protein degradation is catalyzed by the ATP/ubiquitin-independent 20S proteasome under normal cell conditions. Arch Biochem Biophys 2010, 500:181-188.
102. Fulga T.A., Elson-Schwab I., Khurana V., Steinhilb M.L., Spires T.L., Hyman B.T., et al. Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo. Nat Cell Biol 2007, 9:139-148.
103. Butterfield D.A., Kanski J. Brain protein oxidation in age-related neurodegenerative disorders that are associated with aggregated proteins. Mech Ageing Dev 2001, 122:945-962.
104. Hensley K., Hall N., Subramaniam R., Cole P., Harris M., Aksenov M., et al. Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. J Neurochem 1995, 65:2146-2156.
105. Aksenov M.Y., Aksenova M.V., Butterfield D.A., Geddes J.W., Markesbery W.R. Protein oxidation in the brain in Alzheimer's disease. Neuroscience 2001, 103:373-383.
106. Reed T., Perluigi M., Sultana R., Pierce W.M., Klein J.B., Turner D.M., et al. Redox proteomic identification of 4-hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease. Neurobiol Dis 2008, 30:107-120.
107. Canton M., Menazza S., Sheeran F.L., Polverino de Laureto P., Di Lisa F., Pepe S. Oxidation of myofibrillar proteins in human heart failure. J Am Coll Cardiol 2011, 57:300-309.
108. Templeton D.L., Mosser K.H.H., Chen C.N., Stone M.D., John R., Dengel D.R., et al. Effects of left ventricular assist device (LVAD) placement on myocardial oxidative stress markers. Heart Lung Circ 2012, 21:586-597.
109. Oikawa S., Yamada T., Minohata T., Kobayashi H., Furukawa A., Tada-Oikawa S., et al. Proteomic identification of carbonylated proteins in the monkey hippocampus after ischemia-reperfusion. Free Radic Biol Med 2009, 46:1472-1477.
110. Schwalb H., Olivson A., Li J., Houminer E., Wahezi S.E., Opie L.H., et al. Nicorandil decreases postischemic actin oxidation. Free Radic Biol Med 2001, 31:607-614.
111. Barreiro E., Gea J., Di Falco M., Kriazhev L., James S., Hussain S.N.A. Protein carbonyl formation in the diaphragm. Am J Respir Cell Mol Biol 2005, 32:9-17.
112. Smerjac S.M., Bizzozero O.A. Cytoskeletal protein carbonylation and degradation in experimental autoimmune encephalomyelitis. J Neurochem 2008, 105:763-772.
113. O'Reilly P.J., Hickman-Davis J.M., Davis I.C., Matalon S. Hyperoxia impairs antibacterial function of macrophages through effects on actin. Am J Respir Cell Mol Biol 2003, 28:443-450.
114. De Marco F., Bucaj E., Foppoli C., Fiorini A., Blarzino C., Filipi K., et al. Oxidative stress in HPV-driven viral carcinogenesis: redox proteomics analysis of HPV-16 dysplastic and neoplastic tissues. PLoS One 2012, 7:e34366.
115. Breusing N., Grimm S., Mvondo D., Flaccus A., Biesalski H.K., Grune T. Light-induced cytotoxicity after aminolevulinic acid treatment is mediated by heme and not by iron. J Photochem Photobiol B 2010, 99:36-43.
116. Kästle M., Grimm S., Nagel R., Breusing N., Grune T. Combination of PDT and inhibitor treatment affects melanoma cells and spares keratinocytes. Free Radic Biol Med 2011, 50:305-312.
117. Grimm S., Mvondo D., Grune T., Breusing N. The outcome of 5-ALA-mediated photodynamic treatment in melanoma cells is influenced by vitamin C and heme oxygenase-1. BioFactors 2011, 37:17-24.
118. Baglo Y., Sousa M.M.L., Slupphaug G., Hagen L., Havag S., Helander L., et al. Photodynamic therapy with hexyl aminolevulinate induces carbonylation, posttranslational modifications and changed expression of proteins in cell survival and cell death pathways. Photochem Photobiol Sci 2011, 10:1137-1145.
119. Gourlay C.W., Carpp L.N., Timpson P., Winder S.J., Ayscough K.R. A role for the actin cytoskeleton in cell death and aging in yeast. J Cell Biol 2004, 164:803-809.
120. Fiaschi T., Cozzi G., Raugei G., Formigli L., Ramponi G., Chiarugi P. Redox regulation of β-actin during integrin-mediated cell adhesion. J Biol Chem 2006, 281:22983-22991.